US FDA approves Emergents smallpox vaccine for people at high risk of mpox
The U.S. Food and Drug Administration granted expanded approval to Emergent BioSolutions smallpox vaccine for use by people at high risk of mpox infection, sending the drugmakers shares surging 20 before the bell on Friday.
Posted by Hicham ALAOUI RIZQ on 2024, Aug 30
Introduction
The U.S. Food and Drug Administration granted expanded approval to Emergent BioSolutions smallpox vaccine for use by people at high risk of mpox infection, sending the drugmakers shares surging 20 before the bell on Friday.
Article Link
Read more: US FDA approves Emergents smallpox vaccine for people at high risk of mpox